ATE485831T1 - Behandlung von neurodegeneration - Google Patents

Behandlung von neurodegeneration

Info

Publication number
ATE485831T1
ATE485831T1 AT06709825T AT06709825T ATE485831T1 AT E485831 T1 ATE485831 T1 AT E485831T1 AT 06709825 T AT06709825 T AT 06709825T AT 06709825 T AT06709825 T AT 06709825T AT E485831 T1 ATE485831 T1 AT E485831T1
Authority
AT
Austria
Prior art keywords
neurodegeneration
treatment
hopn
minimally
polypeptides
Prior art date
Application number
AT06709825T
Other languages
English (en)
Inventor
Joanna Iczkiewicz
Peter Jenner
Original Assignee
Proximagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proximagen Ltd filed Critical Proximagen Ltd
Application granted granted Critical
Publication of ATE485831T1 publication Critical patent/ATE485831T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT06709825T 2005-02-18 2006-02-17 Behandlung von neurodegeneration ATE485831T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65396005P 2005-02-18 2005-02-18
PCT/GB2006/000589 WO2006087579A1 (en) 2005-02-18 2006-02-17 Treatment for neurodegeneration

Publications (1)

Publication Number Publication Date
ATE485831T1 true ATE485831T1 (de) 2010-11-15

Family

ID=36129947

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06709825T ATE485831T1 (de) 2005-02-18 2006-02-17 Behandlung von neurodegeneration

Country Status (5)

Country Link
US (1) US7790687B2 (de)
EP (1) EP1848453B1 (de)
AT (1) ATE485831T1 (de)
DE (1) DE602006017806D1 (de)
WO (1) WO2006087579A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008086449A2 (en) * 2007-01-09 2008-07-17 Oregon Health & Science University Synthetic osteopontin peptides and methods of use
US8189323B2 (en) * 2008-12-02 2012-05-29 Mitsubishi Electric Corporation Gas-insulated switchgear apparatus
EP2780363B1 (de) * 2011-11-17 2019-07-03 Glia SP Z.O.O. Zusammensetzungen und verfahren zur behandlung eines glioms
US11058720B2 (en) 2016-05-20 2021-07-13 Cedars-Sinai Medical Center Methods of treating or preventing alzheimer's disease and associated conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092122A2 (en) * 2001-05-17 2002-11-21 Applied Research Systems Ars Holding N.V. Use of osteopontin for the treatment and/or prevention of neurologic diseases

Also Published As

Publication number Publication date
WO2006087579A1 (en) 2006-08-24
EP1848453A1 (de) 2007-10-31
EP1848453B1 (de) 2010-10-27
US20090137463A1 (en) 2009-05-28
DE602006017806D1 (de) 2010-12-09
US7790687B2 (en) 2010-09-07

Similar Documents

Publication Publication Date Title
PT1171465E (pt) Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
ATE415413T1 (de) Iap-bindende verbindungen
DK1434791T3 (da) Specifikke bindingsmidler til human angiopoietin-2
NO20063026L (no) Antistoffer
IN2014CN02050A (de)
DK1521774T3 (da) Trunkerede Tau-proteiner
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
CY1109631T1 (el) Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
WO2007036299A3 (de) Verfahren zur amidierung von polypeptiden mit c-terminalen basischen aminosäuren unter verwendung spezifischer endoproteasen
ATE491349T1 (de) Neue nutrazeutika-zusammensetzungen
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
ATE401400T1 (de) Antiangiogene peptide zur behandlung oder vorbeugung von endometriose
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
ATE485831T1 (de) Behandlung von neurodegeneration
DE60332579D1 (de) Prozess zur Immobilisierung von Polypeptiden über die Carboxylgruppe des C-terminus
EP1978994A4 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
EA200800205A1 (ru) Кальций-пептидный компонент
DE60235505D1 (de) Neues verfahren und neue zusammensetzung zur hemmurwendung von verbindungen auf basis einer sequenz in mmp-2
EP1666880A4 (de) Screening-verfahren
ATE467643T1 (de) Peptide mit proliferationshemmender wirkung
WO2008014054A3 (en) Bmp-7 variant compositions, methods and uses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties